Sign in

BHST on Nasdaq

BIOHARVEST SCIENCES INC.

BIOHARVEST SCIENCES INC. is a Canadian pharmaceutical preparations company based in Vancouver.2 Its shares trade on Nasdaq under the symbol BHST.2

Price unavailable

Last updated Oct 21, 2026.

Overview

$34.5MRevenue, fiscal 20253
-$11.1MNet income, fiscal 20253

Compare with Verrica Pharmaceuticals Inc., Earth Science Tech, Inc. or Arcus Biosciences, or pick any stock.

  • TickerBHST on Nasdaq2
  • IndustryPharmaceutical Preparations2
  • HeadquartersVancouver, Canada2
  • Incorporated inBritish Columbia, Canada4
  • Business address1140 - 625 Howe Street, Vancouver, A1 V6C 2T64
  • Filer category, Emerging growth company4
  • Legal formCorporation2
  • LEI549300FZ6YR4YH454R702
  • StatusActive2
  • LEI statusIssued and current2
  • Registered address1140 - 625 Howe Street, V6C 2T6 Vancouver, Canada2
  • Registered withBC Registry Services, BC09679872

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

59.3%Gross margin3
-16.2%Operating margin3
-32.3%Net margin3
37.0%Revenue growth, 20253
-43.8%Return on equity3
-$9.6MFree cash flow3

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

North America brought in 84% of the revenue BIOHARVEST SCIENCES INC. broke down this way in fiscal 2025.

  1. North America$30.6M384%up 33% from 2024
  2. Israel$3.9M311%up 80% from 2024
  3. CDMO Services$1.9M35%up 566% from 2024
Business segments by year
Business segments20242025
North America$23.0M$30.6M
Israel$2.2M$3.9M
CDMO Services$282.0K$1.9M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue41¢$14.0M
  • Research and development15¢$5.3M
  • Other costs44¢$15.1M
  • Income tax0¢$76.0K

Out of $34.5M in revenue.3 The company lost money this year.

Financial statements

Revenue53$34.5M in 2025+172% since 2023
0$10.0M$20.0M$30.0M$40.0M2023: $12.7M$12.7M20232024: $25.2M$25.2M2024+99%2025: $34.5M$34.5M2025+37%
Gross profit53$20.5M in 2025+264% since 2023
0$10.0M$20.0M$30.0M2023: $5.6M$5.6M20232024: $13.9M$13.9M2024+148%2025: $20.5M$20.5M2025+47%
Operating income53-$5.6M in 2025−44% since 2023
-$10.0M-$7.5M-$5.0M-$2.5M02023: -$10.0M-$10.0M20232024: -$7.0M-$7.0M2024−30%2025: -$5.6M-$5.6M2025−20%
Net income53-$11.1M in 2025−11% since 2023
-$15.0M-$10.0M-$5.0M02023: -$12.6M-$12.6M20232024: -$12.9M-$12.9M2024+3%2025: -$11.1M-$11.1M2025−14%

Every line of the income statement as filed: the last 2 fiscal years, latest first.3

Period ending2025-12-312024-12-31
Revenues$34.5M$25.2M
Cost of revenues-$14.0M-$11.2M
Gross profit$20.5M$13.9M
Research and development-$5.3M-$4.8M
Sales and marketing-$15.8M-$11.7M
General and administrative-$4.9M-$4.4M
Total operating expenses-$26.1M-$20.9M
Operating loss-$5.6M-$7.0M
Finance income$54.0K$0
Finance expenses-$5.5M-$5.9M
Net loss before tax-$11.1M-$12.9M
Taxes on income-$76.0K-$8.0K
Net loss and comprehensive loss-$11.1M-$12.9M
Basic and diluted loss per share-$0.60-$0.80
Weighted average number of shares outstanding18.4M shares16.2M shares

Compare BIOHARVEST SCIENCES INC. with another company

Corporate structure

BIOHARVEST SCIENCES INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of BIOHARVEST SCIENCES INC.

  • Vivien Rakib Filed SCHEDULE 13G on BIOHARVEST SCIENCES INC., latest Feb 12, 2025
  • BIOHARVEST SCIENCES INC. Vancouver, British Columbia, Canada

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What BIOHARVEST SCIENCES INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$10.5M3 Dec 31, 2025$9.9M3 Dec 31, 2024+6.2%
Accumulated depreciation$2.2M3 Dec 31, 2025$2.1M3 Dec 31, 2024+1.5%
Property and equipment, net$8.3M3 Dec 31, 2025$7.8M3 Dec 31, 2024+7.4%
Operating-lease assets (leased space)$8.4M3 Dec 31, 2025$9.0M3 Dec 31, 2024−6.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$23.0M3 Dec 31, 2025$2.4M3 Dec 31, 2024+863.4%

Inventory

ItemLatestA year beforeChange
Inventory, total$4.6M3 Dec 31, 2025$3.7M3 Dec 31, 2024+24.7%

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerBar K Dichter named Oct 6, 20256
  • Executive OfficerBrian K Cornblatt named Oct 25, 2022 to Oct 6, 20256
  • Executive OfficerDavid K Ryan named Oct 25, 2022 to Oct 6, 20256
  • Executive OfficerIlan K Sobel named Oct 25, 2022 to Oct 6, 20256
  • Executive OfficerIlana K Belzer named Oct 6, 20256
  • Executive OfficerJared K Turner named Oct 6, 20256
  • Executive OfficerMalkit K Azachi named Oct 6, 20256
  • Executive OfficerMichal K Sapir named Oct 6, 20256
  • Executive OfficerYochi K Hagay named Oct 25, 2022 to Oct 6, 20256
  • Executive Officer, DirectorZaki K Rakib named Oct 25, 2022 to Oct 6, 20256
  • Executive OfficerAlan K Rootenberg named Oct 25, 2022 to Jan 11, 20247
  • DirectorAnne K Binder named Oct 6, 20256
  • DirectorDavid K Tsur named Oct 25, 2022 to Oct 6, 20256
  • DirectorJake K Fiddick named Oct 25, 2022 to Oct 6, 20256
  • DirectorSharon K Malka named Oct 6, 20256
  • DirectorVivien K Rakib named Oct 25, 2022 to Oct 6, 20256

Former names

  • CANNA-V-CELL SCIENCES INC.Oct 8, 2019 to Apr 21, 20204
  • Midnight Star Ventures Corp.Nov 24, 2017 to Oct 15, 20184

Timeline

  1. Apr 20, 2013Founded BIOHARVEST SCIENCES INC. is founded2

Calendar

Coming up

  1. Nov 12, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported ($0.14) a share, on Nov 13, 2025.8

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

126 filings to the SEC since October 2021: 2 annual reports, 1 large holders, 5 private raises, 118 other. The latest 20:

  1. Oct 13, 20266-K REPORT EDGAR
  2. Oct 8, 20266-K REPORT EDGAR
  3. Oct 2, 20266-K REPORT EDGAR
  4. Sep 15, 20266-K REPORT EDGAR
  5. Sep 15, 20266-K REPORT EDGAR
  6. Sep 14, 20266-K REPORT EDGAR
  7. Sep 3, 20266-K REPORT EDGAR
  8. Aug 12, 20266-K REPORT EDGAR
  9. Aug 11, 20266-K REPORT EDGAR
  10. Jul 29, 20266-K REPORT EDGAR
  11. Jul 28, 20266-K REPORT EDGAR
  12. Jul 16, 20266-K REPORT EDGAR
  13. Jul 15, 20266-K REPORT EDGAR
  14. Jun 18, 20266-K REPORT EDGAR
  15. May 28, 20266-K REPORT EDGAR
  16. May 14, 20266-K REPORT EDGAR
  17. May 14, 20266-K REPORT EDGAR
  18. May 14, 20266-K REPORT EDGAR
  19. May 13, 20266-K REPORT EDGAR
  20. May 12, 20266-K REPORT EDGAR

The 126 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

  • Vivien RakibSCHEDULE 13G, 1 filing Feb 12, 20259

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Sep 19, 2025Raised $401,348 in a private offering of equity Form D: 2 investors so far Form D
  2. Dec 27, 2023Raised $498,881 in a private offering of debt Form D: 4 investors so far Form D
  3. Oct 30, 2023Raised $4.1 million in a private offering of debt Form D: 4 investors so far Form D
  4. Jul 18, 2023Raised $344,587 in a private offering of debt Form D: 2 investors so far Form D
  5. Oct 13, 2022Raised $2 million in a private offering of debt Form D: 4 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Alyeska Investment Group, L.P.581,441$1.7M0.0%−175,623
Evercore Wealth Management, LLC216,343$618.7K0.0%+76,873
True North Advisors, LLC187,318$535.7K0.1%+19,305
Magnus Financial Group LLC90,000$257.4K0.0%+35,000
Susquehanna International Group, Llp63,658$179.5K0.0%+47,264
Silverberg Bernstein Capital Management LLC57,723$162.8K0.1%+31,624
King Luther Capital Management Corp40,000$114.4K0.0%No change
TD Waterhouse Canada Inc.23,827$65.5K0.0%No change
Citadel Advisors LLC20,652$58.2K0.0%+5,899
XTX Topco Ltd13,232$37.3K0.0%−16,417
Geode Capital Management, LLC10,558$29.8K0.0%−1,253
K.J. Harrison & Partners Inc10,000$27.9K0.0%New
Morgan Stanley3,250$9.3K0.0%No change
Osaic Holdings, Inc.571$1.6K0.0%−57
Thompson Siegel & Walmsley LLC364,008$1.0K0.0%−22,751
UBS Group AG173$4950.0%−456
National Bank Of Canada /fi/154$4230.0%No change
Caitong International Asset Management Co., Ltd2$60.0%New
Royal Bank Of Canada9$00.0%−3,000

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How BIOHARVEST SCIENCES INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARBIOHARVEST SCIENCES INC.1
  • CIK0001723464
  • Filer status<br>emerging growth company an emerging growth company1
  • Incorporated inCanada10
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address1140 - 625 Howe Street, Vancouver, A1 V6C 2T61
  • Phone60462211861
  • Shares outstanding22,666,842 as of Dec 31, 20253
  • On EDGAR sinceNov 24, 20171
  • Filings135 in all: 6-K (92), D (13), UPLOAD (5), 20FR12G/A (3), 424B7 (3), 40-F (2), CERT (2), SEC STAFF LETTER (2)1
    All 21 form types

    20FR12G (1), 424B5 (1), 8-A12B (1), AW (1), CORRESP (1), D/A (1), DEL AM (1), EFFECT (1), F-3 (1), F-X (1), POS AM (1), S-8 (1), SCHEDULE 13G (1)

  • Latest filingsAnnual report (40-F) Mar 31, 2026

Securities registered for trading

ClassSymbolExchange
Common shares, without par valueBHSTNASDAQ

From the cover page of the 40-F filed Mar 31, 2026 (Section 12(b) of the Exchange Act).10

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10